drugset / Trial / NCT06833008
A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours
RandomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to determine the appropriate dosage, safety and effectiveness of a new study drug IPN01195 in adults with advanced solid tumours. The participants in this study will have advanced solid tumours. 'Advanced solid tumours' refers to cancers that can occur in several places, including cancers in organs or tissues that have spread from their original site to nearby tissues or other parts of the body.
Timeline
- Start
- 2025-03-14
- Primary completion
- 2028-10-03
- Completion
- 2028-10-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IPN01195 | Unknown | — | — |
Indications
No indication recorded.